BioScience Managers
Overview
Bioscience Managers is an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare . The firm invests in private and public healthcare companies with clear technological and market advantages in any territory, and is confident that its engagement with management will deliver commercial success and returns for investors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Saluda Medical | Apr 2023 | Series F | - |
| SeaDragon Marine Oils | Mar 2020 | Convertible Debt | Co-investor |
| Canary Medical Inc. | May 2018 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioScience Managers based?
BioScience Managers is headquartered in Melbourne, Victoria, Australia.
When was BioScience Managers founded?
BioScience Managers was founded in 2003.
How many portfolio companies does BioScience Managers have?
BioScience Managers has 3 portfolio companies in Caplight's dataset.
What are some companies in BioScience Managers's portfolio?
Recent investments visible on Caplight include Saluda Medical, SeaDragon Marine Oils, SeaDragon Marine Oils, Canary Medical Inc., SeaDragon Marine Oils.
What was BioScience Managers's most recent investment?
BioScience Managers's most recent investment on Caplight was in Saluda Medical in 2023.
What sectors does BioScience Managers focus on?
BioScience Managers focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does BioScience Managers focus on?
BioScience Managers typically invests at the MultiStage stage.
What is BioScience Managers's AUM?
BioScience Managers's assets under management are estimated between $50.0M and $100.0M.